A Four-Year Journey Utilising In-House Devices for Clinical Trials

• Implementation of IVDR in 2022 strictly limited the use of lab developed tests (LDTs) in clinical trials
• Discovery Life Sciences’ Kassel Germany facility is a qualified Health Institution and has 4 years of experience utilizing LDTs to support patient management in EU clinical trials under IVDR
• Discovery’s approach to developing clinical trial assays (CTA) under this system will be discussed along with illustrative case studies

Speakers:

T Scott Reid

Vice President & Global Head of Companion Diagnostics

Discovery Life Sciences